Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Thalomid thalidomide: Pilot data; marketed to treat cutaneous manifestations of erythema nodosum leprosum (ENL)

In an open label pilot study of 7 men with

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE